{"filings":[{"id":91215,"accession_number":"0001552781-26-000198","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2026-04-06T23:59:59+00:00","items":["1.01","1.02","2.01","3.01","3.03","5.03","5.01","5.02","9.01"],"status":"ready","headline":"SWK Holdings acquired by Runway Growth Finance; stockholders get 1.7264 RWAY shares or $20.59 cash per share","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Merger completed April 6, 2026; each SWKH share converted into either 1.7264 RWAY shares or $20.59 cash plus $0.74 guaranteed cash payment.","SWKH notified Nasdaq to suspend trading and delist its common stock; plans to file Form 15 to suspend SEC reporting.","All pre-merger officers and directors of SWKH resigned; RWAY appointees now serve as directors and officers.","SWKH's First Horizon Bank credit facility terminated and all outstanding obligations repaid in full.","SWKH became a wholly-owned subsidiary of RWAY; certificate of incorporation and bylaws replaced with RWAY's."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101178,"accession_number":"0001552781-26-000183","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2026-03-31T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"SWK Holdings shareholders approve merger with Runway Growth Finance Corp.","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["11,240,819 shares voted FOR merger agreement; only 8,763 against; proposal approved.","Non-binding advisory compensation and director compensation proposals also approved.","Adjournment proposal not needed due to sufficient votes for merger.","Merger with Runway Growth Finance Corp. (RWAY) is a key milestone; closing subject to other conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101177,"accession_number":"0001628280-26-008158","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2026-02-13T23:59:59+00:00","items":["2.03","9.01"],"status":"ready","headline":"SWK Holdings reduces credit facility from $10M to $7.5M, amends covenants","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Aggregate credit commitments reduced from $10.0M to $7.5M via Seventh Amendment effective Feb 12, 2026.","Financial covenants amended to exclude Royalties Disposition and a one-time Dec 31, 2025 portfolio reclassification adjustment through Mar 31, 2026.","Borrower repaid all obligations to Woodforest National Bank pursuant to a payoff letter.","Borrower represents no Event of Default exists and reconfirms collateral liens in favor of First Horizon Bank.","All other Credit Agreement terms remain unchanged and in full force."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117529,"accession_number":"0001628280-25-055596","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-12-05T23:59:59+00:00","items":["2.03","9.01"],"status":"ready","headline":"SWK Holdings reduces credit facility from $60M to $10M via Sixth Amendment","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Aggregate lender commitments cut from $60.0M to $10.0M effective December 4, 2025.","First Horizon Bank commitment set at $7.5M; Woodforest National Bank at $2.5M.","Amendment modifies June 2023 Credit Agreement; no Event of Default is continuing.","Borrower reaffirms all security interests and liens on collateral securing obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117528,"accession_number":"0001552781-25-000439","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-12-04T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"FTC grants early termination of HSR waiting period for SWK Holdings merger with Runway Growth","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["FTC granted early termination of HSR waiting period on December 2, 2025, satisfying one condition for the merger.","Merger with Runway Growth Finance Corp. requires stockholder approval and other customary conditions.","Closing expected in first quarter of 2026.","Merger Agreement announced on October 9, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117527,"accession_number":"0001628280-25-050153","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SWK Holdings Q3 net income rises to $8.8M; effective yield reaches 16.9%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 GAAP net income $8.8M ($0.72/diluted share) vs $3.5M ($0.28) YoY; revenue $10.9M, up 4.8%.","Finance receivables segment adjusted net income $8.1M vs $5.0M YoY; net portfolio $245.4M.","Effective yield 16.9% (multi-year high), up 230 bps YoY; realized yield 17.3%.","On Oct 9, 2025, entered merger agreement with Runway Growth Finance Corp; expected close late Q4 2025 or Q1 2026.","Repurchased 87,927 shares for $1.3M in Q3; YTD repurchases 199,218 shares for $3.1M."],"consensus_eps_estimate":null,"consensus_eps_actual":1.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":32766000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117526,"accession_number":"0001552781-25-000317","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-10-10T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"SWK Holdings to be acquired by Runway Growth Finance in stock/cash merger; key holder backing","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Stockholders can elect cash or stock; expected guaranteed cash payment of ~$0.74/share from Parent External Adviser.","Key stockholder Double Black Diamond Offshore Ltd., holding ~69.9% of SWKH voting power, agrees to vote in favor.","Termination fee of $8,225,000 payable by SWK under certain circumstances, including change of recommendation.","Closing conditions include stockholder approval, NASDAQ listing of Parent stock, HSR waiting period, and no lower collar trigger.","Merger structured as three-step process: Acquisition Sub merges into SWK, then into Intermediary Sub, then into Parent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117525,"accession_number":"0001552781-25-000315","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-10-09T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"SWK Holdings to be acquired by Runway Growth Finance in ~$220M deal","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total purchase price approx. $220M based on SWK's 6/30/25 NAV; includes $75.5M in RWAY shares and ~$145M cash.","Runway Growth's investment adviser will contribute an additional $9M cash for distribution to SWK stockholders.","SWK portfolio valued at ~$242M (22 companies); healthcare exposure for combined entity rises to ~31% from 14%.","Transaction expected to close in late 2025 or Q1 2026, subject to SWK shareholder and regulatory approvals.","Carlson Capital L.P. signed a Voting Agreement supporting the transaction; SWK board unanimously approved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":117524,"accession_number":"0001628280-25-043460","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-10-01T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"SWK Holdings receives $27.8M loan payoff from Elutia, expects $2.8M incremental income","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Received $27.8M payoff from Elutia, exceeding net GAAP carrying value of $23.9M as of June 30, 2025.","Repayment follows Elutia's sale of BioEnvelope business to Boston Scientific for $88M cash.","Expects to recognize $1.4M from accelerated exit fee recognition and $1.4M from loan loss reserve release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133951,"accession_number":"0001628280-25-040422","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-08-14T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"SWK Holdings Q2 GAAP net income $3.5M; sells royalty portfolio, pays $4/share special dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $3.5M ($0.29/diluted share) vs $3.7M ($0.30) YoY; revenue $10.1M, -6.5%.","Finance receivables segment adjusted non-GAAP net income $4.6M, up from $2.6M in Q2 2024.","Sold majority of royalty portfolio for $34M; paid $49.1M ($4.00/share) special dividend.","After quarter close, sold MOD3 assets at slight premium to book value, simplifying the business.","Net finance receivables $237.6M (-10.4% YoY); effective yield 14.1%; GAAP book value $20.23/share."],"consensus_eps_estimate":null,"consensus_eps_actual":0.66,"consensus_revenue_estimate":null,"consensus_revenue_actual":21884000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.78,"calibrated_materiality_score":0.78,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133950,"accession_number":"0001628280-25-035236","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-07-17T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"SWK Holdings completes sale of MOD3 contract mfg business to AptarGroup for ~$6.9M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price approximately $6.9M, includes cash previously paid under option, subject to indemnification holdback.","Assets sold are substantially all of MOD3 Pharma's contract manufacturing, formulation, and development services business.","Transaction closed July 15, 2025, after Aptar exercised exclusive option granted under March 2024 Option Agreement.","SWK intends to file the Purchase Agreement as an exhibit to its Q2 2025 Form 10-Q."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150692,"accession_number":"0001628280-25-031621","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-06-16T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"SWK Holdings shareholders approve 2010 equity plan extension to 2030; elect directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plan amendment to extend 2010 Equity Incentive Plan to June 13, 2030 approved by stockholders.","Jerry Albright, Laurie L. Dotter, and Robert K. Hatcher elected directors until 2026 annual meeting.","Ratification of BPM LLP as independent auditor for FY2025; say-on-pay approved on advisory basis.","Vote results: Plan amendment 9,696,192 for; director votes each exceeded 10.4 million for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150691,"accession_number":"0001628280-25-026397","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-05-19T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"SWK Holdings authorizes $10M share repurchase program","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized repurchase of up to $10.0 million of common stock.","Program runs May 19, 2025 through May 19, 2026.","Repurchases executed under Rule 10b5-1 and Rule 10b-18 trading plan.","Timing and number of shares depend on market conditions; no guarantee of exact amount.","Board may suspend or discontinue program at any time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150690,"accession_number":"0001628280-25-025966","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-05-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SWK Holdings publishes Q1 2025 investor presentation; details not extractable from excerpt","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company released an investor presentation on May 15, 2025 covering Q1 2025 results.","Presentation includes non-GAAP financial measures with reconciliations.","Exact financial figures (revenue, EPS, etc.) are not available from the truncated exhibit text.","Presentation will be used in meetings with investors and other stakeholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150689,"accession_number":"0001628280-25-025962","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-05-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SWK Holdings Q1 2025 GAAP net income $4.5M, up from $0.5M; $4.00 special dividend paid","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 2025 GAAP net income $4.5M ($0.37/diluted share) vs $0.5M ($0.04) in Q1 2024.","Revenue $11.8M, up 3.5% YoY; finance receivables segment adjusted non-GAAP net income $8.6M (vs $2.3M).","GAAP book value per share $23.94, up 6.8% YoY; non-GAAP tangible financing book value per share $21.73, up 10.5%.","After quarter end, sold majority of royalty portfolio for ~$34M and paid $4.00 per share special dividend.","Effective yield on finance receivables 14.5% (up 30 bps); net finance receivables $223.1M, down 14.5% YoY."],"consensus_eps_estimate":0.2958,"consensus_eps_actual":0.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":11832000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":150688,"accession_number":"0001628280-25-017350","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-04-10T23:59:59+00:00","items":["2.01","7.01","8.01","9.01"],"status":"ready","headline":"SWK Holdings closes $34M royalty sale, declares $4.00 special dividend","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Closed sale of majority of royalty portfolio to Soleus Capital affiliate for $34M cash.","Special cash dividend of $4.00/share declared; payable May 8, 2025 to holders of record April 24.","CEO says sale valued assets at approx GAAP carrying value; retains ~$220M life science loan portfolio.","Pro forma shows 2024 net income would have been $7.9M vs $13.5M as reported after removing royalty income."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169633,"accession_number":"0001628280-25-013999","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-03-20T23:59:59+00:00","items":["1.01","7.01","8.01","9.01"],"status":"ready","headline":"SWK Holdings monetizes royalty portfolio for $51.3M; plans dividend","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["ANI Pharmaceuticals exercised buyout of Iluvien royalty for ~$17.3M.","Definitive agreement with Soleus Capital to sell remaining performing royalties for ~$34.0M.","Total $51.3M represents ~$1.0M gain over book value of $50.3M as of Dec 31, 2024.","Soleus transaction expected to close in ~2 weeks; dividend to be declared at closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169632,"accession_number":"0001628280-25-013997","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-03-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SWK Holdings publishes investor presentation, no specific financial details disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company released investor presentation dated March 2025 for use with investors.","Presentation includes non-GAAP financial measures with reconciliation, but no figures provided in filing.","Filing does not contain any new material event or financial update beyond the presentation.","No specific business changes, guidance, or operational metrics disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":169631,"accession_number":"0001628280-25-013994","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2025-03-20T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SWK Holdings Q4 2024 net income $5.9M, revenue up 25%; monetizes royalty portfolio for $51.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP net income $5.9M ($0.48/diluted) vs $2.8M ($0.23) YoY; total revenue $12.4M, up 25%.","Finance receivables segment adjusted non-GAAP net income $6.2M, up from $3.7M; effective yield 15.5% (+150bps YoY).","Non-GAAP tangible financing book value $21.15/share, +8.3% YoY; GAAP book value $23.45, +5%.","March 2025 monetized performing royalty portfolio for ~$51.3M; dividend anticipated soon after closing.","New loans: $8M Triple Ring, expanded Eton to $30M, $15M Impremed; three royalty positions on nonaccrual ($13.8M)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186694,"accession_number":"0001552781-24-000608","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-11-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SWK Holdings posts investor presentation; no material new information provided","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Company published investor presentation slides covering life science financing strategy.","Presentation includes non-GAAP financial measures with reconciliations to GAAP.","No earnings results, guidance changes, or material operational updates disclosed.","Filing is a routine Regulation FD disclosure; no admission of materiality."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186693,"accession_number":"0001628280-24-047913","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-11-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SWK Holdings Reports Q3 2024 Net Income of $3.5 Million, Revenue Up 15.6%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2024 GAAP net income was $3.5 million, compared to $4.5 million in Q3 2023.","Total revenue increased 15.6% to $10.4 million, driven by finance receivables segment.","Net finance receivables grew 14.4% to $255.9 million as of September 30, 2024.","Closed $11.0 million royalty financing with Relief Therapeutics and $25.7 million amendment with Eton Pharmaceuticals.","GAAP book value per share rose 3.7% to $22.94; repurchased ~340,000 shares YTD for $5.8 million."],"consensus_eps_estimate":null,"consensus_eps_actual":0.61,"consensus_revenue_estimate":null,"consensus_revenue_actual":32625000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186692,"accession_number":"0001628280-24-042129","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-10-03T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Marcus Pennington resigns from SWK Holdings Board effective Oct 1, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Marcus Pennington resigned from the Board of Directors on Sept 30, 2024; effective Oct 1, 2024.","Resignation did not result from any disagreement with the Company's operations, policies, or practices.","Company and Nominating Committee will consider Board composition and search for replacement director candidates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203252,"accession_number":"0001552781-24-000495","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-08-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SWK Holdings publishes investor presentation; no material new details disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filing furnishes an investor presentation dated August 15, 2024, under Regulation FD.","Presentation content is not fully included in the excerpt; only the title and forward-looking statement are visible.","No specific financial metrics, guidance changes, or material events are reported in the available text.","Company states it may use the presentation in investor meetings; non-GAAP reconciliations are provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203251,"accession_number":"0001552781-24-000494","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-08-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SWK Holdings Q2 2024 revenue up 21% to $11.5M; GAAP net income $4.4M vs $3.9M YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Finance receivables segment revenue rose 15.3% to $10.7M; adjusted non-GAAP net income fell to $6.5M from $7.6M YoY.","Provision for credit losses totaled $4.1M driven by impairments on Trio ($2.1M) and Exeevo ($2.2M) loans.","Non-accrual finance receivables were $22.4M at June 30, 2024; portfolio includes Flowonix, Exeevo, Ideal Implant, Best ABT, Trio.","Post-quarter closed up to $11M royalty financing with Relief Therapeutics; $5.8M advanced at close.","Non-GAAP tangible financing book value per share grew 6.4% to $20.17; GAAP book value per share $22.75."],"consensus_eps_estimate":null,"consensus_eps_actual":0.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":22585000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203250,"accession_number":"0001552781-24-000405","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-07-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SWK Holdings names new CFO, repurchases $1M in stock, provides portfolio updates","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Adam Rice, CPA, joined as CFO in July; Courtney Baker promoted to Controller.","Repurchased 58,567 shares for $1.0M in Q2; YTD through July 15 bought 197,969 shares for $3.4M.","Funded $2.0M term loan to AOTI in May; Journey Medical drew $5.0M additional term loan in June.","Journey Medical can draw incremental $5.0M upon FDA approval of DFD-29 (PDUFA Nov 4, 2024).","Portfolio companies AOTI, Biolase, Biotricity, Elutia, Eton, Journey, Shield reported progress."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203249,"accession_number":"0001552781-24-000394","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-07-08T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"SWK Holdings appoints Adam Rice as CFO, promotes Courtney Baker to Controller","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Adam Rice appointed CFO effective July 3, 2024; also named principal financial and accounting officer.","Rice's compensation: $302,500 base salary, 60% cash bonus target, $100,000 restricted stock grant vesting over 4 years.","Courtney Baker promoted from Assistant Controller to Controller, effective immediately.","Rice brings 18+ years of finance leadership; previously CFO of Park Cities Asset Management."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219591,"accession_number":"0001552781-24-000381","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-06-17T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"SWK Holdings annual meeting results: all director nominees elected, auditors ratified, say-on-pay approved","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Directors Albright, Dotter, Hatcher, and Pennington elected with >10.7M votes each; broker non-votes 293,428.","Appointment of BPM LLP as independent auditor ratified: 11.4M for, 708k against.","Advisory vote on executive compensation approved: 11.1M for, 740k against, 2.7k abstain."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219590,"accession_number":"0001552781-24-000357","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-05-20T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"SWK Holdings authorizes $10M share repurchase program through May 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized up to $10M of common stock repurchases from May 16, 2024 to May 16, 2025.","Repurchases will be made under a Rule 10b5-1 trading plan; timing depends on market conditions.","Board may suspend or discontinue the program at any time in its sole discretion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":219589,"accession_number":"0001552781-24-000344","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-05-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SWK Holdings Q1 net income falls 80% to $0.9M on $6M loan impairment; revenue up 25.5%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income of $0.9M ($0.07 diluted EPS) vs $4.6M ($0.36) in Q1 2023.","Revenue rose 25.5% to $11.8M; finance receivables segment revenue hit near-record $11.5M.","Finance segment adjusted non-GAAP net income fell to $2.7M from $7.3M, reflecting $6.0M loan impairment.","Gross finance receivables grew 10.3% YoY to $274.5M; non-accrual loans totaled $26.8M.","Enteris signed exclusive option agreement with strategic partner; received initial low-single-digit million option fee in April."],"consensus_eps_estimate":null,"consensus_eps_actual":0.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":11779000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239405,"accession_number":"0001552781-24-000172","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-03-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"SWK Holdings files investor presentation; no specific new disclosures in filing excerpt","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Filed investor presentation dated March 2024 as Exhibit 99.1 under Item 7.01.","Presentation covers collaborative approach to life science financing, but content is not fully available in the provided excerpt.","No specific financial figures, guidance, or material events were identified from the limited exhibit text.","Non-GAAP measures are included in the presentation with reconciliations referenced in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239404,"accession_number":"0001552781-24-000165","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-03-21T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"SWK Holdings Q4 net income $2.8M flat YoY; finance receivables up 16% to $288.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP net income $2.8M, flat YoY; full year 2023 net income $15.9M vs $13.5M in 2022.","Finance receivables segment adjusted net income $3.7M (-16% YoY); portfolio effective yield 14.0%.","Closed $55.1M in new financings; gross finance receivables $288.4M (+16% YoY).","Enteris subsidiary: $8.4M goodwill impairment; signed Exclusive Option to sell tangible assets for ~$6M.","Repurchased 14,233 shares in Q4; another 51,169 shares YTD through Mar 14, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":239403,"accession_number":"0001552781-24-000138","cik":1089907,"company_name":"SWK Holdings Corp","ticker":"SWKHL","form_type":"8-K","filed_at":"2024-03-19T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"SWK grants Aptar exclusive option to acquire Enteris GMP assets for ~$6M plus fee","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exclusive option to buy Enteris's GMP manufacturing and clinical supply assets; option expires Jan 1, 2026.","Option fee low-single digit millions, payable in two installments; first fee due upon execution.","Exercise price ~$6M plus inventory/prepaids; increases at high single digit CAGR if no exercise within 6 months.","Aptar guarantees mid-single digit million minimum revenue for 2024-2025 under existing collaboration.","If exercised, SWK retains excluded assets; transition services to be negotiated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}